![Arthur Stril](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 66 949 $ al 31/05/2026
Arthur Stril currently works at Primera Therapeutics, Inc., as Director from 2023, Cellectis SA, as Chief Financial & Business Officer from 2024, and Corps des Mines, as Member.
Mr. Stril received his undergraduate degree from École Normale Supérieure and graduate degree from the University of Cambridge.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
CELLECTIS S.A. 0,03 % | 15/02/2026 | 18.651 ( 0,03 % ) | 66 949 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| CELLECTIS S.A. | Director Financiero/CFO | 02/05/2024 |
Corps des Mines | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cellectis SA
 Cellectis SA Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops immunotherapies | Health Technology |
École Normale Supérieure
 École Normale Supérieure Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Corps des Mines |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
Elige MarketScreener 
